Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Robert A. Roth, Omar Kana, David Filipovic & Patricia E. Ganey. (2022) Pharmacokinetic and toxicodynamic concepts in idiosyncratic, drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 18:7-8, pages 469-481.
Read now
Read now
J.T. Tang, L.M. Andrews, T. van Gelder, Y.Y. Shi, R.H.N. van Schaik, L.L. Wang & D.A. Hesselink. (2016) Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerations. Expert Opinion on Drug Metabolism & Toxicology 12:5, pages 555-565.
Read now
Read now
Alan Boobis, Jean-Baptiste Watelet, Rhys Whomsley, Margherita Strolin Benedetti, Pascal Demoly & Keith Tipton. (2009) Drug interactions. Drug Metabolism Reviews 41:3, pages 486-527.
Read now
Read now
Articles from other publishers (45)
Amani Abderahmene, Marith I. FranckeLouise M. AndrewsDennis A. HesselinkDorra AmorWissal Sahtout, Marwa AjmiHayfa MastouriAli BouslamaDorsaf Zellama, Asma OmezzineBrenda C. M. De Winter. (2023) A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus for Tunisian Adults after Renal Transplantation. Therapeutic Drug Monitoring.
Crossref
Crossref
María Cruz del Rocío Terrones-Gurrola, Patricia Ponce-Peña, José Manuel Salas-Pacheco, Abelardo Camacho-Luis, Amaury de Jesús Pozos-Guillén, Guillermo Nieto-Delgado, Olga Dania López-Guzmán & Angel Antonio Vértiz-Hernández. (2023) Arsenic: A Perspective on Its Effect on Pioglitazone Bioavailability. International Journal of Environmental Research and Public Health 20:3, pages 1901.
Crossref
Crossref
Alina A. Bagdasaryan, Vladimir N. Chubarev, Elena A. Smolyarchuk, Vladimir N. Drozdov, Ivan I. Krasnyuk, Junqi Liu, Ruitai Fan, Edmund Tse, Evgenia V. Shikh & Olga A. Sukocheva. (2022) Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy. Cancers 14:21, pages 5436.
Crossref
Crossref
Sairah Hafeez Kamran, Kanwal Rehman, Muhammad Sajid Hamid Akash, Amjad Khan & Ismail Laher. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
281
304
.
Jean Popovici, Kieran Tebben, Benoit Witkowski & David Serre. (2021) Primaquine for Plasmodium vivax radical cure: What we do not know and why it matters. International Journal for Parasitology: Drugs and Drug Resistance 15, pages 36-42.
Crossref
Crossref
Aida Aljabri, Fatimah Alnaim & Yasin Alsaleh. (2020) Combined homozygous 21 hydroxylase with heterozygous P450 oxidoreductase mutation in a Saudi boy presented with hypertension. BMJ Case Reports 13:9, pages e233942.
Crossref
Crossref
David S. RiddickAnne K. Mullen Grey. (2020) Mechanisms of NADPH – cytochrome P450 oxidoreductase induction by dexamethasone in the H4IIE rat hepatoma cell line. Canadian Journal of Physiology and Pharmacology 98:5, pages 267-274.
Crossref
Crossref
Takahiro Nakamura, Mio Fukuda, Ryosuke Matsukane, Kimitaka Suetsugu, Noboru Harada, Tomoharu Yoshizumi, Nobuaki Egashira, Masaki Mori & Satohiro Masuda. (2020) Influence of POR*28 Polymorphisms on CYP3A5*3-Associated Variations in Tacrolimus Blood Levels at an Early Stage after Liver Transplantation. International Journal of Molecular Sciences 21:7, pages 2287.
Crossref
Crossref
Joseph L. Dempsey & Julia Yue Cui. (2019) Microbiome Is a Functional Modifier of P450 Drug Metabolism. Current Pharmacology Reports 5:6, pages 481-490.
Crossref
Crossref
Christian Schulz, Sarah Kammerer & Jan-Heiner Küpper. (2019) NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies. Clinical Hemorheology and Microcirculation 73:1, pages 249-260.
Crossref
Crossref
Jemal Hussien Ahmed, Eyasu Makonnen, Alan Fotoohi, Abraham Aseffa, Rawleigh Howe & Eleni Aklillu. (2019) CYP2D6 Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer Patients. Cancers 11:9, pages 1353.
Crossref
Crossref
Yingzi Ming & Meng Yu. 2018. Genetic Diversity and Disease Susceptibility. Genetic Diversity and Disease Susceptibility.
Wiesława Kranc, Maciej Brązert, Katarzyna Ożegowska, Mariusz Nawrocki, Joanna Budna, Piotr Celichowski, Marta Dyszkiewicz-Konwińska, Maurycy Jankowski, Michal Jeseta, Leszek Pawelczyk, Małgorzata Bruska, Michał Nowicki, Maciej Zabel & Bartosz Kempisty. (2017) Expression Profile of Genes Regulating Steroid Biosynthesis and Metabolism in Human Ovarian Granulosa Cells—A Primary Culture Approach. International Journal of Molecular Sciences 18:12, pages 2673.
Crossref
Crossref
Ibrahim El-Serafi, Ylva Terelius, Manuchehr Abedi-Valugerdi, Seán Naughton, Maryam Saghafian, Ali Moshfegh, Jonas Mattsson, Zuzana Potácová & Moustapha Hassan. (2017) Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway. PLOS ONE 12:11, pages e0187294.
Crossref
Crossref
Huijie Li, Suyun Li, Qiang Wang & Chongqi Jia. (2016) Associations of cytochrome P450 oxidoreductase genetic polymorphisms with smoking cessation in a Chinese population. Human Genetics 135:12, pages 1389-1397.
Crossref
Crossref
Marta Rysz, Ewa Bromek & Wſadysſawa A. Daniel. (2016) Activation of brain serotonergic system by repeated intracerebral administration of 5-hydroxytryptophan (5-HTP) decreases the expression and activity of liver cytochrome P450. Biochemical Pharmacology 99, pages 113-122.
Crossref
Crossref
Frederique Rodieux, Melanie Wilbaux, Johannes N. van den Anker & Marc Pfister. (2015) Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children. Clinical Pharmacokinetics 54:12, pages 1183-1204.
Crossref
Crossref
Ibrahim El-Serafi, Parvaneh Afsharian, Ali Moshfegh, Moustapha Hassan & Ylva Terelius. (2015) Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation. PLOS ONE 10:11, pages e0141979.
Crossref
Crossref
Peter Hlavica. 2015. Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450. Monooxygenase, Peroxidase and Peroxygenase Properties and Mechanisms of Cytochrome P450
247
297
.
Payman Shahabi, Gérard Siest, Urs A. Meyer & Sophie Visvikis-Siest. (2014) Human cytochrome P450 epoxygenases: Variability in expression and role in inflammation-related disorders. Pharmacology & Therapeutics 144:2, pages 134-161.
Crossref
Crossref
Edmond Changkyun Park, Seung Il Kim, Yeonhee Hong, Jeong Won Hwang, Gun-Sik Cho, Hye-Na Cha, Jin-Kwan Han, Chul-Ho Yun, So-Young Park, Ik-Soon Jang, Zee-Won Lee, Jong-Soon Choi, Soohyun Kim & Gun-Hwa Kim. (2014) Inhibition of CYP4A Reduces Hepatic Endoplasmic Reticulum Stress and Features of Diabetes in Mice. Gastroenterology 147:4, pages 860-869.
Crossref
Crossref
Dennis A. Hesselink, Rachida Bouamar, Laure Elens, Ron H. N. van Schaik & Teun van Gelder. (2013) The Role of Pharmacogenetics in the Disposition of and Response to Tacrolimus in Solid Organ Transplantation. Clinical Pharmacokinetics 53:2, pages 123-139.
Crossref
Crossref
Joseph McGraw. 2014. Handbook of Pharmacogenomics and Stratified Medicine. Handbook of Pharmacogenomics and Stratified Medicine
323
340
.
Virginie Y. Martiny & Maria A. Miteva. (2013) Advances in Molecular Modeling of Human Cytochrome P450 Polymorphism. Journal of Molecular Biology 425:21, pages 3978-3992.
Crossref
Crossref
Jing-Jing Zhang, Hua Zhang, Xiao-Liang Ding, Sheng Ma & Li-Yan Miao. (2012) Effect of the P450 oxidoreductase *28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers. European Journal of Clinical Pharmacology 69:4, pages 807-812.
Crossref
Crossref
Chunja Lee, Xinxin Ding & David S. Riddick. (2013) The Role of Cytochrome P450–Dependent Metabolism in the Regulation of Mouse Hepatic Growth Hormone Signaling Components and Target Genes by 3-Methylcholanthrene. Drug Metabolism and Disposition 41:2, pages 457-465.
Crossref
Crossref
David S. Riddick, Xinxin Ding, C. Roland Wolf, Todd D. Porter, Amit V. Pandey, Qing-Yu Zhang, Jun Gu, Robert D. Finn, Sebastien Ronseaux, Lesley A. McLaughlin, Colin J. Henderson, Ling Zou & Christa E. Flück. (2013) NADPH–Cytochrome P450 Oxidoreductase: Roles in Physiology, Pharmacology, and Toxicology. Drug Metabolism and Disposition 41:1, pages 12-23.
Crossref
Crossref
Lei Hu, Wei Zhuo, Yi-Jing He, Hong-Hao Zhou & Lan Fan. (2012) Pharmacogenetics of P450 oxidoreductase. Pharmacogenetics and Genomics 22:11, pages 812-819.
Crossref
Crossref
Xuan Chen, Li Qiang Pan, Hua Naranmandura, Su Zeng & Shu Qing Chen. (2012) Influence of Various Polymorphic Variants of Cytochrome P450 Oxidoreductase (POR) on Drug Metabolic Activity of CYP3A4 and CYP2B6. PLoS ONE 7:6, pages e38495.
Crossref
Crossref
Ulrich M. Zanger, Kathrin Klein & Jessica Rieger. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
259
284
.
Junling Yang, Minxia M. He, Wei Niu, Steven A. Wrighton, Li Li, Yang Liu & Chuan Li. (2012) Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes. British Journal of Clinical Pharmacology 73:2, pages 268-284.
Crossref
Crossref
Alexander V. LyubimovMatthew J. Hutzler & Matthew A. Cerny. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
40
.
Toshiro Niwa, Katsuhito Minami & Masanao Katagiri. (2012) Effect of Histidine-tag and R457H and E580Q Mutations on Catalytic Activity of Recombinant Human Cytochrome P450 Oxidoreductase. Drug Metabolism and Pharmacokinetics 27:1, pages 150-154.
Crossref
Crossref
Christopher C. Marohnic, Warren J. Huber III, J. Patrick Connick, James R. Reed, Karen McCammon, Satya P. Panda, Pavel Martásek, Wayne L. Backes & Bettie Sue S. Masters. (2011) Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization. Archives of Biochemistry and Biophysics 513:1, pages 42-50.
Crossref
Crossref
Robert Landsiedel, Eric Fabian, Tewes Tralau & Andreas Luch. (2011) Chemical toxicity testing in vitro using cytochrome P450–expressing cell lines, such as human CYP1B1. Nature Protocols 6:5, pages 677-688.
Crossref
Crossref
Donald G. Robertson, Stefan U. Ruepp, Steven A. Stryker, Serhiy Y. Hnatyshyn, Petia A. Shipkova, Nelly Aranibar, Colleen A. Mcnaney, Oliver Fiehn & Michael D. Reily. (2011) Metabolomic and Transcriptomic Changes Induced by Overnight (16 h) Fasting in Male and Female Sprague−Dawley Rats. Chemical Research in Toxicology 24:4, pages 481-487.
Crossref
Crossref
Yoshiro Saito, Noboru Yamamoto, Noriko Katori, Keiko Maekawa, Hiromi Fukushima-Uesaka, Daisuke Sugimoto, Kouichi Kurose, Kimie Sai, Nahoko Kaniwa, Jun-ichi Sawada, Hideo Kunitoh, Yuichiro Ohe, Teruhiko Yoshida, Yasuhiro Matsumura, Nagahiro Saijo, Haruhiro Okuda & Tomohide Tamura. (2011) Genetic Polymorphisms and Haplotypes of POR, Encoding Cytochrome P450 Oxidoreductase, in a Japanese Population. Drug Metabolism and Pharmacokinetics 26:1, pages 107-116.
Crossref
Crossref
Xiaojie Zhou, Mei Li, Chengfa Sheng & Xinghui Qiu. (2011) NADPH-cytochrome P450 oxidoreductase from the chicken (Gallus gallus): Sequence characterization, functional expression and kinetic study. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 153:1, pages 53-59.
Crossref
Crossref
Vishal Agrawal, Ji Ha Choi, Kathleen M. Giacomini & Walter L. Miller. (2010) Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase. Pharmacogenetics and Genomics 20:10, pages 611-618.
Crossref
Crossref
Natalia A. Petushkova, Mikhail A. Pyatnitskiy, Andrey V. Lisitsa, Olesya V. Larina, Galina P. Kuznetsova, Oleg G. Skipenko, Irina I. Karuzina & Alexander I. Archakov. (2010) Computational approach to characterization of human liver drug-metabolizing enzymes. European Journal of Pharmaceutical Sciences 41:2, pages 305-311.
Crossref
Crossref
Diana M. Feidt, Kathrin Klein, Andreas Nüssler & Ulrich M. Zanger. (2009) RNA‐Interference Approach to Study Functions of NADPH : Cytochrome P450 Oxidoreductase in Human Hepatocytes. Chemistry & Biodiversity 6:11, pages 2084-2091.
Crossref
Crossref
. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Ana M Gomes, Stefan Winter, Kathrin Klein, Miia Turpeinen, Elke Schaeffeler, Matthias Schwab & Ulrich M Zanger. (2009) Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation. Pharmacogenomics 10:4, pages 579-599.
Crossref
Crossref
Dong-Hyun Kim, Sung-Kun Yim, Keon-Hee Kim, Taeho Ahn & Chul-Ho Yun. (2008) Continuous spectrofluorometric and spectrophotometric assays for NADPH-cytochrome P450 reductase activity using 5-cyano-2,3-ditolyl tetrazolium chloride. Biotechnology Letters 31:2, pages 271-275.
Crossref
Crossref
Xuan Ye, Yuguang Wang, Minghui Yang, Qingqing Wang, Qiande Liang, Zengchun Ma, Boli Zhang & Yue Gao. (2009) Investigating the in vitro metabolism of veratridine: Characterization of metabolites and involved cytochrome P450 isoforms. Journal of Chromatography B 877:3, pages 141-148.
Crossref
Crossref